Satoshi Hirakawa
Hamamatsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and Lymphangiomatosis 2022.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: December 24, 2025
Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022.
Journal: Journal of plastic and reconstructive surgery
Published: December 23, 2025
Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022.
Journal: The Journal of dermatology
Published: November 09, 2025
Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis 2022.
Journal: Japanese journal of radiology
Published: October 27, 2025
Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis 2022.
Journal: Surgery today
Published: October 27, 2025
Translating Evidence to Practice: Advancing Equitable Access to Dermatologic Care for Radiation Dermatitis Worldwide.
Journal: International journal of radiation oncology, biology, physics
Published: August 20, 2025
Reemergence of Mycoplasma pneumoniae in Post-COVID-19 Japan: A 2024 Outbreak in Hokkaido After 5 Years.
Journal: The Pediatric infectious disease journal
Published: July 28, 2025
A randomized, double-blind, placebo-controlled phase III study evaluating the preventive effect of diclofenac cream on capecitabine-related hand-foot syndrome: study protocol of J-SUPPORT2401/JORTC-SUP06 (J-DIRECT).
Journal: International journal of clinical oncology
Published: March 24, 2025
Fatal Spitz Melanoma With MAD1L1::BRAF Fusion: A Case Report and Literature Review.
Journal: Journal of cutaneous pathology
Published: September 27, 2024
Sirolimus treatment for intractable vascular anomalies (SIVA): An open-label, single-arm, multicenter, prospective trial.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: May 14, 2024
A significant outbreak of respiratory human adenovirus infections among children aged 3-6 years in Hokkaido, Japan, in 2023.
Journal: Journal of medical virology
Published: March 26, 2024
Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial.
Journal: Frontiers in medicine
Published: November 09, 2023
Last Updated: 09/26/2026